Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Impact of vein-to-vein time in patients with R/R LBCL treated with axicabtagene ciloleucel.
Journal: Blood advances
Published: July 25, 2024
Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B-cell lymphoma after 2 or more lines of prior therapy.
Journal: American journal of hematology
Published: November 08, 2023
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma.
Journal: The New England journal of medicine
Published: June 05, 2023
CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicity.
Journal: Journal for immunotherapy of cancer
Published: March 23, 2023
High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia-like fusions.
Journal: American journal of hematology
Published: November 02, 2022
Landscape of germline cancer predisposition mutations testing and management in pediatrics: Implications for research and clinical care.
Journal: Frontiers in pediatrics
Published: August 04, 2022
Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days.
Journal: Blood advances
Published: April 01, 2021
Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma.
Journal: Journal for immunotherapy of cancer
Published: March 10, 2021
Late and very late relapsed acute lymphoblastic leukemia: clinical and molecular features, and treatment outcomes.
Journal: Blood cancer journal
Published: February 12, 2021
Combined immune checkpoint blockade increases CD8+CD28+PD-1+ effector T cells and provides a therapeutic strategy for patients with neuroblastoma.
Journal: Oncoimmunology
Published: January 25, 2021
Diagnostic approach to the evaluation of myeloid malignancies following CAR T-cell therapy in B-cell acute lymphoblastic leukemia.
Journal: Journal for immunotherapy of cancer
Published: October 19, 2020
Last Updated: 09/26/2026